ASCENEURON

Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need... Asceneuron was founded in 2012 through a spin-off of Merck Serono's Alzheimer's drug discovery portfolio and research group in Switzerland. We are a privately held company financed by a strong syndicate of investors consisting of Sofinnova Partners, SR One, Johnson & Johnson Innovation - JJDC, Inc. (JJDC), Kurma Partners and Merck Ventures.

Also known as: Asceneuron SA

Primary location: Lausanne Switzerland